{"ticker": {"uuid": "a5326af4-77be-4395-99c7-44c3ce3e2bcc", "symbol": "1477", "name": "Ocumension Therapeutics", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Morrison Foerster guides OcuMension Therapeutics on Alcon asset acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPWFM4bjRIQkRleFlSbkRIOEFxY3NBMnlBVERJNG9zRGU2RnJpNTFsRkdXSVJqd1o2M0tDSXQtQjhUdXc2ZUNEVWhxY0d6NHFoMmMxUWdqOV9UTjV4TDBhR1Q3eDRHTFZNM1NqUFBTaEgxZzJ3Z0xFTzAtSWQ0aW5fTzRRZkFtOXN3M0pnVXBCcWVva0ZvNll1d214UVF0bFUxM3oyLUhDNA?oc=5", "source_name": "ICLG", "published_at": "2024-08-19T07:00:00+00:00", "published_display": "19 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ocumension Therapeutics Appoints Mr. Tim RUAN and Mr. WANG Chong as Chief Financial Officer and Head of Investor Relations respectively", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwJBVV95cUxPRnNGdzVSbkJoQ0pYV1RqQkNKc2ROMkJqVGZzZWkzcGRETkRCV2lhYWNEaTJWN2s3dXQzdzZxUzNXZTlhOGR4YUVRaHpzVWk5TWE3N3NLTDYwZllwM01nSkd0Y0txY3puUmJ1aFA5UzUyQWxMYTQ2NUhMOHBKYkNRNXZRcndvWFpFU0t6cWFCNW1WVlM1a29UaVJ0R3lhY0RxdTRvbTh4YmY1QXJKQUkwd2N2RGY4ak9fWFFkbFBCOFo1VWJha2lLVnIxT19lN3YxNTRaTUFTUS1sTjRSTkVkSjhic0lmOEt3WnI0dWhEMTIzeXJSS1RVNGdOdkh5cThSUXN2dktQVzhVeWJhNzBlN0J1eGdnOGpsSkxz?oc=5", "source_name": "ACN Newswire", "published_at": "2023-01-30T08:00:00+00:00", "published_display": "30 Jan 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China\u2019s NMPA gives green light to Ocumension\u2019s Yutiq intravitreal implant for uveitis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNek5BaXAzckhLbU4zQzNteHFETGhtbGNFUjhLQnRiX2RZZlFsSWhrbTF4VU1HUHlZVE1yOHNLU0RRbURZOWoyUkVkcmt5bHpUamZaY09lNVVHMzZUN3cxNXhsU0ZhWDNtbjRwa1VZWWwxZzFlc1hCV1M5V010c241QnhFLVVncVU1dmVvdnZQMzJYMlRPeWNLSVlKRko2eWRyU1A3LUpnVHdWd01zUms0VzJFTFE1YU1QcXNTS09oakh0UQ?oc=5", "source_name": "BioWorld News", "published_at": "2022-06-21T07:00:00+00:00", "published_display": "21 Jun 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OCUMENSION THERAPEUTICS - B (1477) - stock price, quote, history", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQSzhVaWpQQ05EdEhFNjlkdUp2WHNIWldWTDR4eXFHLUxuU01hOGtXUVZmanpzaFVtLUJFaktoUUEyS3BYVlFwUFlhbGZFeFJpNzA1TGtneGJfVzhPbThqU2Vnc1IxVkFFMFlza2ZDOHRCVk5mSld3SWVBcHBhZnpiZTBFTC0xSjZOU1ZYc2RyUQ?oc=5", "source_name": "hkex.com.hk", "published_at": "2020-07-10T07:00:00+00:00", "published_display": "10 Jul 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Morrison Foerster guides OcuMension Therapeutics on Alcon asset acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPWFM4bjRIQkRleFlSbkRIOEFxY3NBMnlBVERJNG9zRGU2RnJpNTFsRkdXSVJqd1o2M0tDSXQtQjhUdXc2ZUNEVWhxY0d6NHFoMmMxUWdqOV9UTjV4TDBhR1Q3eDRHTFZNM1NqUFBTaEgxZzJ3Z0xFTzAtSWQ0aW5fTzRRZkFtOXN3M0pnVXBCcWVva0ZvNll1d214UVF0bFUxM3oyLUhDNA?oc=5", "source_name": "ICLG", "published_at": "2024-08-19T07:00:00+00:00", "published_display": "19 Aug 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ocumension Therapeutics Appoints Mr. Tim RUAN and Mr. WANG Chong as Chief Financial Officer and Head of Investor Relations respectively", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwJBVV95cUxPRnNGdzVSbkJoQ0pYV1RqQkNKc2ROMkJqVGZzZWkzcGRETkRCV2lhYWNEaTJWN2s3dXQzdzZxUzNXZTlhOGR4YUVRaHpzVWk5TWE3N3NLTDYwZllwM01nSkd0Y0txY3puUmJ1aFA5UzUyQWxMYTQ2NUhMOHBKYkNRNXZRcndvWFpFU0t6cWFCNW1WVlM1a29UaVJ0R3lhY0RxdTRvbTh4YmY1QXJKQUkwd2N2RGY4ak9fWFFkbFBCOFo1VWJha2lLVnIxT19lN3YxNTRaTUFTUS1sTjRSTkVkSjhic0lmOEt3WnI0dWhEMTIzeXJSS1RVNGdOdkh5cThSUXN2dktQVzhVeWJhNzBlN0J1eGdnOGpsSkxz?oc=5", "source_name": "ACN Newswire", "published_at": "2023-01-30T08:00:00+00:00", "published_display": "30 Jan 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China\u2019s NMPA gives green light to Ocumension\u2019s Yutiq intravitreal implant for uveitis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNek5BaXAzckhLbU4zQzNteHFETGhtbGNFUjhLQnRiX2RZZlFsSWhrbTF4VU1HUHlZVE1yOHNLU0RRbURZOWoyUkVkcmt5bHpUamZaY09lNVVHMzZUN3cxNXhsU0ZhWDNtbjRwa1VZWWwxZzFlc1hCV1M5V010c241QnhFLVVncVU1dmVvdnZQMzJYMlRPeWNLSVlKRko2eWRyU1A3LUpnVHdWd01zUms0VzJFTFE1YU1QcXNTS09oakh0UQ?oc=5", "source_name": "BioWorld News", "published_at": "2022-06-21T07:00:00+00:00", "published_display": "21 Jun 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OCUMENSION THERAPEUTICS - B (1477) - stock price, quote, history", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQSzhVaWpQQ05EdEhFNjlkdUp2WHNIWldWTDR4eXFHLUxuU01hOGtXUVZmanpzaFVtLUJFaktoUUEyS3BYVlFwUFlhbGZFeFJpNzA1TGtneGJfVzhPbThqU2Vnc1IxVkFFMFlza2ZDOHRCVk5mSld3SWVBcHBhZnpiZTBFTC0xSjZOU1ZYc2RyUQ?oc=5", "source_name": "hkex.com.hk", "published_at": "2020-07-10T07:00:00+00:00", "published_display": "10 Jul 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 76, "total_relevant": 4, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 4, "score": 50, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 71, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 5.07, "latest_week": "2026-07-10", "one_week_move": -0.4, "four_week_move": -3.4, "twelve_week_move": -38.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.010723, "market_dynamics_buy_signal": false, "relative_strength": -30.872845, "fair_value_gap": -25.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.3963, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.4% over one week, -3.4% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 45, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "ICLG", "count": 1}, {"label": "ACN Newswire", "count": 1}, {"label": "BioWorld News", "count": 1}, {"label": "hkex.com.hk", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "71/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.4% over one week, -3.4% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Morrison Foerster guides OcuMension Therapeutics on Alcon asset acquisition"}], "updated_at": "2026-07-17T18:10:59.476890+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}